Stay updated on Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedThe study record now shows the trial as Completed with updated dates and a new Informed Consent Form linked under Study Documents; the previous Active, not recruiting status and related dates have been removed.SummaryDifference1.0%

- Check10 days agoChange DetectedAdds key affiliations and personnel (The Jamesline; Ohio State University Comprehensive Cancer Center; Dwight Owen) and collaborators, clarifying who runs the study and with whom. Also adds data-sharing language (Plan to Share IPD) and related MeSH terms, improving the study's metadata, discoverability, and contextual framing.SummaryDifference61%

- Check17 days agoChange DetectedRevision changed from v3.6.4 to v3.6.5, signaling a minor maintenance update to the page template or content. No substantive study information or functionality appears to be altered.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing v3.6.3. This reflects a small update to the page’s documentation/versioning.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a minor maintenance update to the page's documentation/versioning. This update does not alter study details or other substantive content presented on the page.SummaryDifference0.1%

- Check60 days agoChange DetectedThe revision label on the page updated from v3.6.0 to v3.6.2, indicating a newer page version. This reflects a backend or frontend adjustment rather than changes to the study data.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.